title: Pharmacological considerations of primary alkylators.
authors.affiliation: Department of Clinical Research, Fred Hutchinson Cancer Rsearch Center, Seattle, Washington, USA.
authors.forename: Jeannine S
authors.initials: JS
authors.lastname: McCune
authors.forename: John T
authors.initials: JT
authors.lastname: Slattery
mesh_terms: D000970:Antineoplastic Agents / Q000493:pharmacokinetics; D018906:Antineoplastic Agents, Alkylating / Q000493:pharmacokinetics*; D002066:Busulfan / Q000493:pharmacokinetics*; D016190:Carboplatin / Q000493:pharmacokinetics; D002330:Carmustine / Q000493:pharmacokinetics; D002945:Cisplatin / Q000493:pharmacokinetics; D003520:Cyclophosphamide / Q000493:pharmacokinetics*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007069:Ifosfamide / Q000493:pharmacokinetics; D013852:Thiotepa / Q000493:pharmacokinetics
chemical_list: D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D003520:Cyclophosphamide; D013852:Thiotepa; D016190:Carboplatin; D002066:Busulfan; D002945:Cisplatin; D002330:Carmustine; D007069:Ifosfamide